INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 64 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $359,000 | -73.4% | 316,146 | -47.3% | 0.00% | -50.0% |
| Q4 2021 | $1,349,000 | +2308.9% | 600,239 | +3597.0% | 0.00% | – |
| Q3 2021 | $56,000 | -87.2% | 16,236 | -88.9% | 0.00% | -100.0% |
| Q2 2021 | $438,000 | -80.4% | 146,742 | -78.8% | 0.00% | -80.0% |
| Q1 2021 | $2,236,000 | +3094.3% | 691,892 | +1759.3% | 0.01% | – |
| Q1 2019 | $70,000 | +40.0% | 37,212 | -12.8% | 0.00% | -100.0% |
| Q4 2018 | $50,000 | -80.8% | 42,671 | -14.0% | 0.00% | -66.7% |
| Q1 2016 | $261,000 | +0.8% | 49,589 | +223.4% | 0.00% | 0.0% |
| Q4 2014 | $259,000 | -0.8% | 15,336 | -21.2% | 0.00% | -25.0% |
| Q3 2014 | $261,000 | – | 19,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,866,108 | $25,408,000 | 4.32% |
| Nine Chapters Capital Management LLC | 91,500 | $296,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,969,225 | $6,361,000 | 0.24% |
| Orbimed Advisors | 3,250,300 | $10,498,000 | 0.12% |
| PINNACLE ASSOCIATES LTD | 1,306,679 | $4,221,000 | 0.08% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 810,232 | $2,617,000 | 0.07% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 270,417 | $873,000 | 0.06% |
| Rock Springs Capital Management LP | 270,000 | $872,000 | 0.05% |
| ALGERT GLOBAL LLC | 39,876 | $129,000 | 0.04% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 391,671 | $1,265,000 | 0.03% |